PARIS (dpa-AFX) - French drug major Sanofi (SNYNF, SNY) reported Thursday
that its first-quarter net income attributable to equity holders, on IFRS basis,
was 1.13 billion euros, down 43.2 percent from last year's 2 billion euros.

Earnings per share declined 43.1 percent to 0.91 euro from 1.60 euros a year
ago.

Business net income was 2.22 billion euros, compared 2.70 billion euros last
year. Business earnings per share were 1.78 euros, compared to 2.16 euros last
year.

IFRS net sales grew 2.4 percent to 10.46 billion euros from last year's 10.22
billion euros. Sales growth was 6.7 percent at constant exchange rates, driven
by launches.

Looking ahead for fiscal 2024, Sanofi continues to expect business earnings per
share to remain roughly stable excluding the impact of an expected effective tax
rate increase to 21 percent, and decrease low single-digit at CER including the
higher expected tax rate.

For more earnings news, earnings calendar, and earnings for stocks, visit
rttnews.com.



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX